ENHANCE: A Randomized, Double-blind Multicenter Study Comparing Magrolimab in Combination with Azacitidine versus Azacitidine Plus Placebo in Treatment-naïve Patients with Higher Risk Myelodysplastic Syndrome

  • Zargari, Ahmad (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: The Alfred HREC ref Project 183/20
NMA SSA Reference Number: SSA/62949/MonH-2020-239665(v2)
Monash Health Reference: RES-20-0000-836X
StatusActive
Effective start/end date9/11/20 → 8/11/25

Keywords

  • Clinical trial
  • treatment efficacy
  • treatment safety
  • Myelodysplastic Syndromes